NewAmsterdam Pharma to participate in September investor conferences
NewAmsterdam Pharma Company N.V. said it will participate at upcoming investor conferences in September.
NAARDEN, The Netherlands and MIAMI, Sept.
02, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) wi…